Sales of contact lenses by Johnson & Johnson fell by 1.3 percent year-on-year in the first quarter to reach $814 million. At constant currency rates, revenues fell by 0.3 percent as the negative impact of the Covid-19 pandemic was partially offset by a double-digit growth rate in the U.S. for daily disposable lenses from the Acuvue Oasys line.

In the U.S. contact lens revenue rose by 7.7 percent to $346 million, while international sales fell by 7.0 percent to $467 million, with sales in local currencies down by 5.4 percent.

For the whole of J&J’s vision care division, sales were down by 5.5 percent to $1,067 million in the quarter, or by 4.5 percent at constant currency rates.